🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Heather A. Parsons

Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa

ORCID: 0000-0001-8178-6612

Also affiliated with Harvard University, University of Washington, Fred Hutch Cancer Center, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center, Dana-Farber Brigham Cancer Center

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile
0.742Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030

medRxiv(2023)10.1101/2023.03.06.23286772
Top 27%
0.742DataRank
Top 27%12 citations

Timothy Blewett, Xiangying Chu, Sainetra Sridhar, Katheryn Santos, Kan Xiong +24 more

Papers

Driven by 11 papers — median percentile 73. Top paper: “Massively parallel enrichment of low-frequency alleles enables duplex sequencing at low depth”.

Massively parallel enrichment of low-frequency alleles enables duplex sequencing at low depth

Nature Biomedical Engineering(2022)10.1038/s41551-022-00855-9
N/A
2.2DataRank · unranked
83 citations

Erica Nguyen, Jin H. Bae, Timothy Blewett, Justin Rhoades, Sarah C. Reed +15 more

Single duplex DNA sequencing with CODEC detects mutations with high sensitivity

Nature Genetics(2023)10.1038/s41588-023-01376-0
N/A
2.0DataRank · unranked
83 citations

Ruolin Liu, Eugenia Roberts, Erica Nguyen, Shervin Tabrizi, Justin Rhoades +20 more

Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030

Annals of Oncology(2023)10.1016/j.annonc.2023.08.004
N/A
1.7DataRank · unranked
58 citations

Timothy Blewett, Xun Chu, Sainetra Sridhar, Katheryn Santos, Kan Xiong +24 more

Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030

medRxiv(2023)10.1101/2023.03.06.23286772
Top 27%
0.742DataRank
Top 27%12 citations

Timothy Blewett, Xiangying Chu, Sainetra Sridhar, Katheryn Santos, Kan Xiong +24 more

Liquid biopsy epigenomic profiling for cancer subtyping

Nature Medicine(2023)10.1038/s41591-023-02605-z
N/A
0.722DataRank · unranked
122 citations

Ji-Heui Seo, Matthew P. Davidsohn, Brad Fortunato, Karl Semaan, Shahabbedin Sotudian +38 more

MAESTRO affords ‘breadth and depth’ for mutation testing

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.01.22.427323
N/A
0.314DataRank · unranked
5 citations

Erica Nguyen, Jin H. Bae, Justin Rhoades, Sarah C. Reed, Douglas Shea +15 more

FinaleMe: Predicting DNA methylation by the fragmentation patterns of plasma cell-free DNA

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.01.02.573710
N/A
0.250DataRank · unranked
3 citations

Sarah C. Reed, Christopher Lo, Atish D. Choudhury, Heather A. Parsons, Daniel G. Stover +12 more

A framework for clinical cancer subtyping from nucleosome profiling of cell-free DNA

Nature Communications(2022)10.1038/s41467-022-35076-w
N/A
0DataRank · unranked
130 citations

Minjeong Ko, Hanna Liao, A. Eden Cruikshank, Katheryn Santos, Caroline Kikawa +18 more

Phase I study of ribociclib (CDK4/6 inhibitor) with spartalizumab (PD-1 inhibitor) with and without fulvestrant in metastatic hormone receptor-positive breast cancer or advanced ovarian cancer

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2024-010430
N/A
0DataRank · unranked
14 citations

Noah Graham, Lestat R. Ali, Christina I. Herold, Jennifer Desrosiers, Khanh Do +13 more

Clonal Hematopoiesis Dynamics and Evolutionary Fitness During Cancer Treatment Impact Clinical Outcomes

medRxiv(2025)10.1101/2025.08.27.25334581
N/A
0DataRank · unranked
2 citations

Yi-Han Tang, Christelle Colin, Sadegh Marzban, Daniel Walgenbach, Stefania Morganti +12 more

A Randomized Phase 2 Study of Neratinib With or Without Fulvestrant for Patients With HER2-Positive, Estrogen Receptor-Positive Metastatic Breast Cancer

Clinical Breast Cancer(2025)10.1016/j.clbc.2025.05.009
N/A
0DataRank · unranked
0 citations

Xiangying Chu, Tarah J. Ballinger, Nisha Unni, Sarah Sinclair, Robert Wesolowski +9 more